|Bid||262.01 x 900|
|Ask||263.57 x 800|
|Day's Range||250.91 - 265.10|
|52 Week Range||84.75 - 279.46|
|Beta (5Y Monthly)||1.49|
|PE Ratio (TTM)||24.77|
|Forward Dividend & Yield||5.68 (2.25%)|
|Ex-Dividend Date||Mar 29, 2021|
|1y Target Est||N/A|
Medifast (MED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Dan Chard, Medifast Chairman & CEO joins the Yahoo Finance Live panel to discuss their Q1 earnings results.
Medifast (MED) could produce exceptional returns because of its solid growth attributes.